Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes.
Daniel
D
D
Interdepartmental Program of Immunology, University of Colorado Health Sciences Center, Denver 80220, USA.
Wegmann
D R
DR
D000281:Administration, Intranasal; D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D004334:Drug Administration Schedule; D005260:Female; D015994:Incidence; D007328:Insulin / Q000008:administration & dosage* / Q000276:immunology / Q000627:therapeutic use; D051379:Mice; D016688:Mice, Inbred NOD; D010446:Peptide Fragments / Q000008:administration & dosage* / Q000276:immunology / Q000627:therapeutic use; D011236:Prediabetic State / Q000628:therapy*; D013997:Time Factors
D007328:Insulin; D010446:Peptide Fragments; C097877:insulin B (9-23)